Novavax vaccine could be approved by JUNE - bringing another 100 million doses of COVID-19 vaccine to the US after drug company announced its final stage clinical trial in ...

Novavax has now enrolled 30,000 people in the US and Mexico to its shot trial Its CEO told Reuters last month it could deliver doses to the US by June if all goes well in its trials. The vaccine was shown to be 89.3% effective and works nearly as well against the UK variant in tests in Britain. But the shot is about 50% less effective against the South African variant. US has a contract for 100 million doses of Novavax's COVID-19 vaccine. It would likely be the fourth shot authorized in the US, assuming Johnson & Johnson's vaccine gets greenlit by the FDA this week